Cell lines are a vitally important tool in life sciences research, especially in the understanding of disease processes and so in developing treatments. However developing cell lines that express the right proteins in the right quantities and that are stable enough to work with is a difficult task.
A UK-based SME has specific expertise in the development of cell lines for research. These cell lines have the characteristics required for research, such as expression of key proteins in the amounts and quality required for a particular research project. The SME's cell lines are also stable, meaning that they retain the ability to express the required protein over time making them suitable for longer term research projects.
The SME is looking to partner with companies, universities and research organisations conducting research that would utilise cell lines. The SME would develop the cell line with the required characteristics for the partner and would expect the partner to provide information on performance in order for the SME to improve its technology and offer. It is envisaged that the partnership will take the form of commercial agreements with technical assistance, manufacturing agreements or technical cooperation agreements. This will depend on the nature of the project and the specific situation of the partner.
Advantages & innovations
The SME has the following advantages:
A great deal of experience in developing cell lines for research projects.
Cell lines developed to exhibit the characteristics required such as level of expression of desired protein.
Cell lines are stable meaning expression levels of protein will not change significantly over the course of a project.
Significantly shortened production time compared to the standard production time: few weeks as opposed to months of traditional cell line development.
Stage of development
Already on the market
Partner sought
The UK SME is looking to partner with companies, universities and research organisations that are working in the fields of drug discovery. The SME will work with these partners to generate proteins of relevance to their programmes with the partner expected to provide feedback on the performance to inform the SME's internal development programme. It is envisaged that the partnership will take the form of a commercial agreement with technical assistance, manufacturing agreement or a technical cooperation agreement depending on the particular situation of the partner.